Quince Therapeutics, Inc. (QNCX) Net income 2018–2025
Quince Therapeutics, Inc. (QNCX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$84.0MFY2025 · since FY2018: -$12.5M → -$84.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$84.0M | -47.8% |
| FY2024 | -$56.8M | -81.0% |
| FY2023 | -$31.4M | +39.2% |
| FY2022 | -$51.7M | +42.6% |
| FY2021 | -$89.9M | -17.0% |
| FY2020 | -$76.8M | -107.8% |
| FY2019 | -$37.0M | -196.4% |
| FY2018 | -$12.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice